The Journal of Organic Chemistry
DCM/MeOH = 5:1) to give the product 15 (290 mg, 93% yield
Page 6 of 8
125.0, 120.9, 120.0, 79.0, 61.2, 54.5, 52.0, 36.4, 35.1, 33.1,
29.7, 27.1, 23.7, 22.0, 7.2. IR (neat) vmax 2936, 2776, 1577,
1454, 1323, 1249, 1193, 1123, 1013, 750 cm-1. HRMS
(ESIMS): calcd for C19H25N2 [M+H]+ 281.2012, found
281.2018. []D24.3 +146.0 (CHCl3, c=1.0).
over two steps) as a white solid. 1H NMR (400 MHz, CDCl3) δ
8.60 (s, 1H), 7.58 (dd, J = 5.6, 2.7 Hz, 1H), 7.19 (dd, J = 6.0,
2.6 Hz, 1H), 7.14 – 7.02 (m, 2H), 3.71 (s, 1H), 3.02 (d, J =
12.0 Hz, 1H), 2.75 (td, J = 11.9, 2.8 Hz, 1H), 2.52 (dd, J = 8.6,
3.8 Hz, 2H), 2.27 (dt, J = 17.8, 8.9 Hz, 1H), 1.81 (d, J = 13.3
Hz, 1H), 1.72 – 1.51 (m, 2H), 1.49 – 1.34 (m, 4H), 1.15 – 0.98
(m, 1H), 0.83 (t, J = 7.5 Hz, 3H). 13C{1H} NMR (100 MHz,
CDCl3) δ 136.1, 134.6, 127.1, 120.7, 119.0, 117.4, 111.1,
110.6, 56.5, 46.0, 34.4, 34.0, 29.3, 23.9, 22.3, 19.8, 7.5. IR
(neat) vmax 3398, 3290, 3150, 3105, 3055, 2930, 2876, 2859,
2744, 1623, 1590, 1465, 1452, 1434, 1379, 1305, 1230, 1167,
1
2
3
4
5
6
7
8
(+)-Winchinine B (1b). To a solution of imine (+)-1,2-
dehydroaspidospermidine 2 (23 mg, 0.082 mmol) in EtOH (1
mL) was added TMSCN (5.0 eq., 0.05 mL, 0.411 mmol). The
mixture was allowed to stir 1.5 h at 30 °C before the solvent
was evaporated under reduced pressure. The residue was puri-
fied by column chromatography on silica gel (eluted with pe-
troleum/EtOAc 20:1 to 10:1) afforded (+)-winchinine B (1b)
(16 mg, 64% yield) as a white solid, along with 5 mg recov-
ered imine 2. The synthetic (+)-winchinine B (1b) matched the
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
1114, 1012, 738 cm-1. HRMS (ESIMS): calcd for C17H23N2
24.1
[M+H]+ 255.1856, found 255.1857. []D
c=1.0); m.p. 171-173 °C.
-30.0 (CHCl3,
analytical data of natural sample.7 1H NMR (400 MHz, CDCl3)
δ 7.05 (m, 2H), 6.80 (dd, J = 7.4 Hz, 1H), 6.63 (d, J = 7.7 Hz,
1H), 3.93 (s, 1H), 3.26 (td, J = 9.0, 4.3 Hz, 1H), 3.04 (br d, J =
10.7 Hz, 1H), 2.67 (m, 1H), 2.36 (s, 1H), 2.29 (m, 1H),
2.24(m,1H), 1.97 (m, 2H), 1.77 (m, 2H), 1.62 (d, J = 13.6 Hz,
1H), 1.49 (m, 2H), 1.39 (dd, J = 14.4, 7.4 Hz, 1H), 1.13 (m,
1H), 1.08 (m, 1H), 0.92 (m, 1H), 0.64 (t, J = 7.5 Hz, 3H).
13C{1H} NMR (100 MHz, CDCl3) δ 146.5, 133.2, 128.2, 123.3,
122.2, 120.8, 111.0, 69.7, 64.8, 57.9, 53.4, 51.8, 36.7, 36.0,
34.3, 32.7, 29.9, 22.1, 21.6, 7.0. IR (neat) vmax 3332, 2935,
2788, 2374, 1687, 1545, 1510, 1466, 1377, 1330, 1181, 1141,
734 cm-1. HRMS (ESIMS): calcd for C20H26N3 [M+H]+
308.2121, found 308.2123. []D24.5 +35.0 (MeOH, c=1.0); m.p.
154-156 °C.
2-((4aR,11cR)-4a-ethyl-2,3,4,4a,5,6,7,11c-octahydro-1H-
pyrido[3,2-c]carbazol-1-yl)ethan-1-ol (3). To a solution of
15 (280 mg, 1.102 mmol) in absolute ethanol (10 mL) were
sequentially added anhydrous potassium carbonate(8 eq., 1.22
g, 8.819 mmol) and 2-bromoethanol (8 eq., 0.64 mL, 8.819
mmol) in a sealed-vessel. The resulting suspension was heated
to 100 °C for 6 h. The reaction mixture was cooled to room
temperature. After removal of EtOH, the residue was purified
by flash chromatography on silica gel (eluted with EtOAc with
2% Et3N) to afford the alkylated product 3 (270 mg, 83% yield)
1
as a yellow solid. H NMR (400 MHz, CDCl3) δ 8.59 (br s,
1H), 7.46 (d, J = 7.5 Hz, 1H), 7.29 (t, J = 10.5 Hz, 1H), 7.21 –
7.06 (m, 2H), 4.50 (s, 1H), 3.73 (ddd, J = 14.3, 7.1, 3.0 Hz,
1H), 3.63 (ddd, J = 14.4, 5.8, 2.9 Hz, 1H), 3.57 – 3.49 (m, 1H),
3.47 (s, 1H), 3.31 – 3.23 (m, 1H), 2.84 – 2.63 (m, 3H), 2.56 –
2.48 (m, 2H), 2.07 (ddd, J = 13.7, 10.4, 6.9 Hz, 1H), 1.99 –
1.88 (m, 1H), 1.65 (dt, J = 13.5, 6.7 Hz, 2H), 1.39 – 1.20 (m,
3H), 0.87 (t, J = 7.5 Hz, 3H). 13C{1H} NMR (100 MHz,
CDCl3) δ 174.6, 136.2, 136.1, 128.1, 121.7, 120.1, 117.5,
111.0, 106.8, 63.6, 59.1, 48.1, 37.0, 29.7, 29.5, 28.0, 26.3,
20.0, 8.1. IR (neat) vmax 3397, 3217, 3185, 3109, 3058, 2937,
2877, 2794, 1620, 1585, 1461, 1377, 1331, 1308, 1265, 1233,
ASSOCIATED CONTENT
Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website.
Full spectroscopic data for all new compounds (PDF).
1169, 1141, 1120, 1041, 739 cm-1. HRMS (ESIMS): calcd for
AUTHOR INFORMATION
Corresponding Author
24.3
C19H27N2O [M+H]+ 299.2118, found 299.2117. []D
(CHCl3, c=1.0); m.p. 86-88 °C.
-3.0
(+)-1,2-dehydroaspidospermidine (2). To a solution of
primary alcohol 3 (74 mg, 0.248 mmol) in THF (12 mL) was
added dropwise a 1 M solution of t-BuOK in THF (3.34 eq.,
0.83 mL, 0.829 mmol) at 0 °C. After stirring for 10 min, TsCl
(1.48 eq., 70 mg, 0.367 mmol) was added and the reaction
mixture was allowed to warm to room temperature. After stir-
ring for 1 h, the reaction was diluted with Et2O and quenched
* E-mail:shexg@lzu.edu.cn. Fax: +86-931-8912582
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENT
This work was supported by the National Science Foundation of
China (21732001, 21871118 and 21572088) and PCSIRT
(IRT_15R28).
o
with water at 0 C. Then the mixture was saturated with NaCl
and extracted with EtOAc three times. The combined organic
layers were dried over MgSO4, filtered and concentrated. The
crude product was purified by column chromatography on
silica gel (eluted with petroleum/EtOAc = 4:1 with 2% Et3N)
to afford (+)-1,2-dehydroaspidospermidine (2) as a pale yel-
low oil (35 mg, 51% yield), which matched the previously
reported analytical data.9a 1H NMR (400 MHz, CDCl3) δ 7.52
(d, J = 7.6 Hz, 1H), 7.35 – 7.26 (m, 2H), 7.17 (dd, J = 10.8,
4.0 Hz, 1H), 3.21 – 3.15 (m, 2H), 3.14 – 3.07 (m, 1H), 2.76
(ddd, J = 14.0, 10.4, 3.4 Hz, 1H), 2.59 (ddd, J = 11.5, 8.5, 5.7
Hz, 1H), 2.45 (td, J = 12.7, 3.2 Hz, 1H), 2.40 (s, 1H), 2.23 –
2.12 (m, 2H), 1.91 – 1.78 (m, 1H), 1.64 (dd, J = 12.4, 5.6 Hz,
1H), 1.61 – 1.52 (m, 2H), 1.51 – 1.44 (m, 1H), 1.00 (td, J =
13.5, 4.9 Hz, 1H), 0.71 – 0.56 (m, 2H), 0.49 (t, J = 7.3 Hz, 3H).
13C{1H} NMR (100 MHz, CDCl3) δ 192.3, 154.4, 147.1, 127.4,
REFERENCES
(1) (a) Saxton, J. E. In The Alkaloids; Cordell, G. A., Eds.; Aca-
demic Press: New York, 1998; Vol. 51, Chapter 1. (b) O’Connor, S. E.
In Comprehensive Natural Products II; Mander, L., Liu, H., Eds.;
Elsevier: Amsterdam, 2010; Vol. 1, p 977.
(2) (a) Malawista, S. E.; Sato, H.; Bensch, K. G. Vinblastine and
Griseofulvin Reversibly Disrupt the Living Mitotic Spindle. Science
1968, 160, 770−772. (b) Jordan, M. A.; Wilson, L. Microtubules as a
target for anticancer drugs. Nat. Rev. Cancer 2004, 4, 253−265. (c)
Gigant, B.; Wang, C.; Ravelli, R. B. G.; Roussi, F.; Steinmetz, M. O.;
Curmi, P. A.; Sobel, A.; Knossow, M. Structural basis for the regula-
tion of tubulin by vinblastine. Nature 2005, 435, 519−522.
(3) Lim, K. -H.; Hiraku, O.; Komiyama, K.; Koyano, T.; Hayashi,
M.; Kam, T. Biologically Active Indole Alkaloids from Kopsia arbor-
ea. J. Nat. Prod. 2007, 70, 1302−1307.
ACS Paragon Plus Environment